Integrated scRNA-seq and bulk transcriptomics identify an amino acid metabolism-associated prognostic signature and highlight FUS as a potential driver in prostate cancer progression - PubMed
3 hours ago
- #Amino Acid Metabolism
- #Prostate Cancer
- #FUS
- Integrated scRNA-seq and bulk transcriptomics used to identify an amino acid metabolism-associated prognostic signature in prostate cancer.
- A 9-gene amino acid metabolic risk signature developed, stratifying patients into distinct prognostic subgroups with robust predictive accuracy.
- FUS identified as a potential oncogenic regulator in prostate cancer progression through multi-omics analyses and experimental validation.
- Study provides a clinically actionable amino acid metabolic signature and suggests FUS as a candidate therapeutic target.
- Findings bridge computational discovery with mechanistic validation, offering insights into amino acid metabolic dependencies in prostate cancer.